729-P: Efficacy and Safety of Mylan Insulin Glargine Products (MYL-1501D) from Two Manufacturing Processes (Process V and Process VI) in Combination with Insulin Lispro in Subjects with Type 1 Diabetes Mellitus

Diabetes ◽  
2021 ◽  
Vol 70 (Supplement 1) ◽  
pp. 729-P
Author(s):  
YARON RAITER ◽  
THOMAS BLEVINS ◽  
BIN SUN ◽  
ANOOP CHULLIKANA ◽  
GOPINATH RANGANNA ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Insulin Glargine ◽  
Type 1 Diabetes Mellitus ◽  
Insulin Lispro ◽  
Manufacturing Processes ◽  
Efficacy And Safety

scholarly journals Efficacy and safety of MYL‐1501D versus insulin glargine in people with type 1 diabetes mellitus: Results of the INSTRIDE 3 phase 3 switch study

2019 ◽  
Vol 22 (3) ◽  
pp. 365-372 ◽  
Author(s):  
Thomas C. Blevins ◽  
Abhijit Barve ◽  
Yaron Raiter ◽  
Patrick Aubonnet ◽  
Sandeep Athalye ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 1 Diabetes ◽  
Insulin Glargine ◽  
Type 1 Diabetes Mellitus ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Switch Study
Sign in / Sign up

Export Citation Format

Share Document